News
NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...
Discover key insights from Roivant Sciences' Q1 2025 earnings call, including brepocitinib DM data milestones, financial strength, and strategic ...
Zacks Investment Research on MSN4h
Merck Stock Down 4% Since Q2 Results: How to Play the Stock
Merck MRK stock has declined 4% since it announced second-quarter results on July 29 before market open. While the company’s ...
Perhaps the most critical aspect of Moderna's business to pay attention to right now is its late-stage pipeline. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback